ABSTRACT INTRODUCTION: Systemic allergic reactions, which include angioedema, are very common in clinical practice. There is great diversity in the etiological factors known to trigger angioedema, and in the pathogenetic mechanisms defi ning this condition. Beside the broad spectrum of immuno-allergic reactions involved in the angioedemic pathogenesis, this condition is known to also develop on the background of other disorders. These disorders may be of different etiology and have different pathogenesis (either non-immune or immune) but have one common feature referred to as "serological overlap". From research and clinical perspective, it is interesting to explore the combination of some rare neurological diseases, such as myopathies and in particular muscular dystrophies with systemic allergic reactions such as angioedema, urticaria and others. It is known that progressive muscular dystrophies (PMD) are hereditary diseases with different types of inheritance -X-chromosome recessive, X-chromosome dominant, autosomal dominant and others. In some forms, such as Duchenne muscular dystrophy (DMD), an increased expression of perforin in muscle is found which is evidence for involvement of the cellular immune response in the pathogenesis of myopathy. It is in this sense that it is interesting to explore and discuss a clinical case diagnosed as a facioscapulohumeral form of PMD, which also manifests angioedema with urticaria. CASE PRESENTATION: We present a 41-year-old male hospitalized in the Division of Occupational Diseases and Allergology at St. George University Hospital in Plovdiv who suffered two incidents of massive angioedema on the face, back and chest, accompanied by an itchy urticarial rash. In 1985, after hospitalization to the Clinic of Neurology, he was diagnosed with PMD of facioscapulohumeral type. The medical history could not reveal any of the most common etiologic factors such as drugs, food, insects and other allergens that may be associated with the systemic allergic reactions. The abnormalities we found (although they are only of specifi c indices of humoral immunity) give some reasons to assume the hypothesis of possible causation between the primary neurological disorder as a trigger for this kind of allergy. CONCLUSION: The reported case demonstrates that in addition to the cellular immunity abnormalities we identifi ed, the abnormalities in some components of humoral immunity should also be taken into consideration. Good knowledge of the allergic factors and the mechanisms of allergic reactions is of paramount importance for an effi cacious approach to the problems faced by patients with such rare pathology.
INTRODUCTION
Systemic allergic reactions, which include angioedema, are very common in clinical practice. There is a great diversity in the etiological factors known to trigger angioedema and in the pathogenetic mechanisms defi ning this condition. Beside the broad spectrum of immuno-allergic reactions that may be involved in the angioedemic pathogenesis, this condition is also known to develop on the background of other disorders. They may have different pathogenesis (either non-immune or immune) and be of different etiology but they share a common feature referred to as "serological overlap". Some neurological diseases, such as myasthenia gravis for example, are known to have also antibodies to other organs and tissues in addition to the organ-specifi c anti-acetylcholine receptor antibodies. There is a tendency for such "layering" between the different organ-specifi c diseases, as well as between them and systems. 1 From research and clinical perspective, it is interesting to explore the combination of another group of rare neurological diseases, such as myopathies and in particular muscular dystrophies with systemic allergic reactions such as angioedema, urticaria etc. It is known that progressive muscular dystrophies (PMD) are hereditary diseases with different types of inheritance -X-chromosome recessive, X-chromosome dominant, autosomal dominant and others. 2 In some forms of this condition (e.g. Duchenne muscular dystrophy), an increased expression of perforin in muscle is found which is evidence for involvement of the cellular immune response in the pathogenesis of myopathy. 3 It is in this sense that it is interesting to explore and discuss a clinical case diagnosed as a facioscapulohumeral form of PMD, which also manifests angioedema with urticaria. 
CASE PRESENTATION

TREATMENT REGIMEN
Steroids (dexamethasone) 40 mg. i.v., chloropyramine (alergosan) 1 ampoule i.m. per day, H1-blocker (alerzan) 10 mg, H2-blocker (famotidine) -2x 40 mg.
The patient was discharged without allergic symptoms.
DISCUSSION
Facioscapulohumeral muscular dystrophy (FSHMD)
is the third most common myopathy. 4 It is characterized by progressive and descendent affecting of facial, shoulder girdle, trunk and lower limbs muscles. ELISA < 30 IU/ml /-/ negative < 30 U/ml anti-SSA (IgG, IgM, IgA) ELISA 1.6 U/ml /-/ negative < 15 U/ml anti-SSB (IgG, IgM, IgA) ELISA 0.7 U/ml /-/ negative < 15 U/ml anti-Sm (IgG, IgM, IgA) ELISA 1.02 U/ml /-/ negative < 15 U/ml anti-Sm RNA (IgG, IgM, IgA) ELISA 1.28 U/ml /-/ negative < 15 U/ml anti-Scl-70 (IgG, IgM, IgA) ELISA < 7.5 U/ml /-/ negative < 7.5 U/ml anti-Jo-1 (IgG, IgM, IgA) ELISA 1.02 U/ml /-/ negative < 15 U/ml anti-histone (IgG, IgM, IgA) ELISA < 20 U/ml /-/ negative < 20 U/ml Anti-neutrophil cytoplasmic antibodies ANCA-MPO (IgG, IgM, IgA) ELISA < 5 U/ml /-/ negative < 5 U/ml ANCA-PR 3 (IgG, IgM, IgA) ELISA < 5 U/ml /-/ negative < 5 U/ml Аntiphospholipid antibodies anti-cardiolipin IgG ELISA 1.16 pl U/ml /-/ negative < 10 gp U/ml anti-cardiolipin IgM ELISA < 7 mpl U/ml anti-beta 2 glycoprotein I / IgM ELISA < 5 U/ml /-/ negative < 5 U/ml anti-beta 2 glycoprotein I / IgG ELISA < 5 U/ml /-/ negative < 5 U/ml Rheumatoid factors (RF) RF IgM ELISA 5.58 IU/ml /-/ negative < 20 IU/ml anti-CCP / IgG ELISA < 25 U/ml /-/ negative < 25 U/ml Anti-rheumatoid antibodies anti-tyroglobulin (ТАТ) IgG ELISA 61.506 IU/ml /-/ negative < 100 U/ml anti-TPO ( DNA analysis has proved a defect (deletion) in the fi nal part of the long arm of the fourth chromosome. 5 Experimental studies indicate the activity of TH1-system as a factor in the pathogenesis of immune-mediated myositis. 6 In some forms of the disease an abnormal expression of specific proteins is found. 7 It is believed that the immune system reacts against this type of neo-antigenes by production of autoantibodies, which gives reason to consider that the genetic predisposition is only a terrain on which the immunological reorganization as this observed in autoimmune myositis takes place.
These changes may at least partially explain the patient's angioedema and urticaria, which normally do not accompany the clinical course of muscular dystrophy. The detected immunological abnormalities are also not typical.
From the laboratory diagnostic methods for this type of myopathies, the following sources of data are defi ning -biopsy-histopathology study of muscle material, electrophysiological (EMG) examination, biochemical indicators etc. 8 The patient has no medical history of intolerance and sensitization to the usual and most common factors and allergens, which trigger allergic reactions, such as angioedema and urticaria -drugs, food, insects, domestic and others allergens. Another reason to exclude was the hereditary angioedema. The negative history (missing inheritance information), typical clinical picture of HAE with dense type of swelling which is more often painful than itchy and laboratory diagnostics, where the level of C1 esterase inhibitor is within the norm, but C4 level is raised, practically exclude HAE option.
The detected in this case elevated levels of total IgE have no signifi cant diagnostic value. As it is known, the clinical signifi cance of the total IgE is to prove atopic predisposition. In addition, high levels of general IgE are not only found in atopy. 9 
CONCLUSIONS
The hypothesis of angioedema and urticaria in the diagnosed FSHMD patient to be determined by the combination of acting in different mechanism factors seams feasible. Registered elevated total IgE and C4 levels, in the absence of patient history, documentaries and other laboratory criteria of atopy, does not rule out the possibility of the two conditions (atopy and PMD), where they have proven genetic markers, to have similar in terms of genetically determined type of inheritance. In this situation, the infl uence of a provoking factor could trigger immuno-allergic reaction, whose mediators, released from the cells and biologically active factors to indicate the clinics of angioedema and/or urticaria.
Based on the detected immunological abnormalities (anti-smooth muscle antibodies, elevated levels of total IgE and C4), it is possible to suppose changes in some components of the humoral immunity at PMD. Whether there is an association between these indicators and on what exactly it is based, can be answered only after further research in larger number of PMD patients.
The described case demonstrates that to the already identifi ed in PMD patient's cellular immunity abnormalities, those in the individual components of humoral immunity should be added, too. The good knowledge of the factors and mechanisms of allergic reactions is a prerequisite for a more effective response to existing problems of the patients with these rare pathologies.
